Dow Jones Top Company Headlines at 5 PM ET: HPE Sales Rise on Networking Growth Despite Cloud and AI Decline | Novo ...

Dow Jones
Mar 10

HPE Sales Rise on Networking Growth Despite Cloud and AI Decline

The server and cloud-software company said networking sales nearly tripled to $2.7 billion, driven in part by a fivefold increase in data center networking revenue.

----

Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers

The agreement brings an end to the legal dispute between the two companies. Hims & Hers shares jumped.

----

Anthropic Sues U.S. Defense Department, Pete Hegseth for Targeting the Company

The AI company named other agencies and officials as defendants as it alleged retaliation for a policy disagreement.

----

Vail Resorts Cuts Guidance After Low Snowfall Deters Skiers

The ski-resort operator said it now expects net income of $144 million to $190 million for the current fiscal year, compared with its initial forecast of $201 million to $276 million.

----

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal

Shell said the divestment allows it to monetize an asset that isn't central to its lubricants portfolio in the U.S. and reinvest in higher-return opportunities.

----

Flying-Taxi Maker Archer Sues Joby, Accusing Rival of Playing Down Reliance on China

The lawsuit filed in California federal court escalates a battle between companies seeking to market new aircraft.

----

First Brands Creditors Shift to Finance Litigation After Restructuring Talks Fail

Bankruptcy lenders are discussing a strategy to bankroll lawsuits aimed at recovering at least some of their losses.

----

Live Nation Reaches Settlement With DOJ in Antitrust Case

The move spares the concerts-and-ticketing giant from the threat of its business being broken up.

----

Nasdaq Partners With Kraken in Plan for 24/7 Tokenized Stock Trading

Nasdaq sought approval in September to let investors trade tokenized versions of its listed stocks and other exchange-traded products.

----

Simon & Schuster Names Former Amazon Executive Greeley as CEO

The publisher is turning to an industry outsider as expanded entertainment options squeeze the book business.

----

Sturm Ruger Accuses Beretta of Attempting to Gain Control of Company

The statement comes after Beretta acquired a nearly 10% stake in Ruger and last month nominated four directors to the company's board, setting the stage for a potential proxy fight between the rival gun makers.

----

Nvidia-Backed Startup Nscale Raises Funds at $14.6 Billion Valuation

Nvidia, Dell Technologies and Nokia were among the investors that backed the AI infrastructure startup's Series C funding round.

----

Activist Starboard Takes Big Stake in French-Fry Maker Lamb Weston

Starboard Value is pushing the company to speed up improvements and cost cutting to boost its underperforming stock.

----

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study

The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a candidate to become a blockbuster treatment.

----

GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.

 

(END) Dow Jones Newswires

March 09, 2026 17:00 ET (21:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10